BCM
PRXL

Bayesian Capital Management’s Parexel International Corp PRXL Stock Holding History

Bayesian Capital Management’s Portfolio PRXL Stock Details PRXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-6,500
Closed -$565K – 728
2017
Q2 		$565K Buy
+6,500
New +$485K 0.21% 162

Other funds holding PRXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Bayesian Capital Management's PRXL Position: Q3 2017 in Review

Bayesian Capital Management sold out of Parexel International Corp (PRXL) in Q3 2017, closing a stake of 6,500 shares — an estimated $565K sold.

Bayesian Capital Management first reported a position in PRXL in Q2 2017 and held it in 1 quarter. The position peaked at $565K in Q2 2017. 246 funds tracked by Wall St. Rank hold PRXL as of Q3 2017.

  • Bayesian Capital Management reported no remaining Parexel International Corp position as of Q3 2017 after selling out during the quarter.
  • Bayesian Capital Management sold 6,500 Parexel International Corp shares in Q3 2017, an estimated $565K.
  • Bayesian Capital Management first reported a position in Parexel International Corp in Q2 2017 and held it in 1 quarter.
  • Bayesian Capital Management's Parexel International Corp position peaked at $565K in Q2 2017.
  • 246 funds tracked by Wall St. Rank held Parexel International Corp as of Q3 2017.

Based on Bayesian Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.